Jazz Pharmaceuticals JAZZ Intrinsic value of stock options exercised
Intrinsic value of stock options exercised at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's intrinsic value of stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's intrinsic value of stock options exercised?
- Jazz Pharmaceuticals (JAZZ) reported intrinsic value of stock options exercised of $5.43M in Q4 2025.
- How has Jazz Pharmaceuticals's intrinsic value of stock options exercised changed year-over-year?
- Jazz Pharmaceuticals's intrinsic value of stock options exercised increased by 10750.0% year-over-year, from $50K to $5.43M.
- What is the long-term trend for Jazz Pharmaceuticals's intrinsic value of stock options exercised?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's intrinsic value of stock options exercised has grown at a -19.5% compound annual growth rate (CAGR), from $51.8M to $21.7M.
- What does intrinsic value of stock options exercised mean?
- The total profit employees made by exercising their stock options.
- How do you interpret intrinsic value of stock options exercised?
- High intrinsic value indicates strong stock performance and significant wealth creation for employees, often correlating with high share dilution.
- How does intrinsic value of stock options exercised compare across companies?
- Commonly reported in proxy statements and equity compensation disclosures.